目次

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to OTC Drugs & Dietary Supplements Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Self-Care in the Global Health System
3.2.1.2 Importance of Dietary Campaigns Driving Market Growth
3.2.2 Market Restraining Factors
3.2.2.1 Concentration of Rx Drugs Likely to Hamper Market Growth
3.2.2.2 Manufacturing Issues to Stifle Industry Growth
3.2.3 Market Opportunities
3.2.3.1 Growth Opportunities will Emerge as a Result of Demographic & Economic Changes
3.2.3.2 Emerging Markets Are Booming
3.2.3.3 Shift Towards Plant-based Supplements
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
3.5.1 Political Factors
3.5.2 Economic Factors
3.5.3 Social Factors
3.5.4 Technological Factors

4 OTC Drugs & Dietary Supplements Industry Structure
4.1 Overview
4.2 Requirements for an OTC Pharmaceutical Drug
4.3 OTC Switching
4.3.1 A Prescription Medicine Switched To OTC
4.3.2 Manufacturing and Distribution of OTC Pharmaceuticals
4.4 Regulation of OTC Pharmaceuticals
4.4.1 U.S.
4.4.2 Japan
4.4.3 Europe
4.4.4 Other Countries

5 OTC Drugs & Dietary Supplements Market Analysis by Category
5.1 Key Findings
5.2 Category Segment Growth Prospects
5.3 OTC Drugs & Dietary Supplements Market Size Estimation and Forecast by Category
5.4 Cough, Cold and Flu Drugs
5.4.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.4.2 Market Share by Region, 2022 & 2032 (%)
5.5 Analgesics
5.5.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.5.2 Market Share by Region, 2022 & 2032 (%)
5.6 Dermatological
5.6.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.6.2 Market Share by Region, 2022 & 2032 (%)
5.7 Vitamins and Minerals
5.7.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.7.2 Market Share by Region, 2022 & 2032 (%)
5.8 Weight Loss/Diet Products
5.8.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.8.2 Market Share by Region, 2022 & 2032 (%)
5.9 Gastrointestinal Drugs
5.9.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.9.2 Market Share by Region, 2022 & 2032 (%)
5.10 Allergy
5.10.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.10.2 Market Share by Region, 2022 & 2032 (%)
5.11 Others
5.11.1 Market Forecast by Region, 2022-2032 (US$ bn)
5.11.2 Market Share by Region, 2022 & 2032 (%)

6 OTC Drugs & Dietary Supplements Market Analysis by Dosage Form
6.1 Key Findings
6.2 Dosage Form Segment Growth Prospects
6.3 OTC Drugs & Dietary Supplements Market Size Estimation and Forecast by Dosage Form
6.4 Tablets
6.4.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.4.2 Market Share by Region, 2022 & 2032 (%)
6.5 Hard Capsules
6.5.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.5.2 Market Share by Region, 2022 & 2032 (%)
6.6 Powders
6.6.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.6.2 Market Share by Region, 2022 & 2032 (%)
6.7 Ointments
6.7.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.7.2 Market Share by Region, 2022 & 2032 (%)
6.8 Soft Capsules
6.8.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.8.2 Market Share by Region, 2022 & 2032 (%)
6.9 Liquids
6.9.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.9.2 Market Share by Region, 2022 & 2032 (%)
6.10 Others
6.10.1 Market Forecast by Region, 2022-2032 (US$ bn)
6.10.2 Market Share by Region, 2022 & 2032 (%)

7 OTC Drugs & Dietary Supplements Market Analysis by Product Type
7.1 Key Findings
7.2 Product Type Segment Growth Prospects
7.3 OTC Drugs & Dietary Supplements Market Size Estimation and Forecast by Product Type
7.4 Branded Drugs
7.4.1 Market Forecast by Region, 2022-2032 (US$ bn)
7.4.2 Market Share by Region, 2022 & 2032 (%)
7.5 Generic Drugs
7.5.1 Market Forecast by Region, 2022-2032 (US$ bn)
7.5.2 Market Share by Region, 2022 & 2032 (%)

8 OTC Drugs & Dietary Supplements Market Analysis by Distribution Channel
8.1 Key Findings
8.2 Distribution Channel Segment Growth Prospects
8.3 OTC Drugs & Dietary Supplements Market Size Estimation and Forecast by Distribution Channel
8.4 Pharmacies/Drugstores
8.4.1 Market Forecast by Region, 2022-2032 (US$ bn)
8.4.2 Market Share by Region, 2022 & 2032 (%)
8.5 Supermarkets/Hypermarkets
8.5.1 Market Forecast by Region, 2022-2032 (US$ bn)
8.5.2 Market Share by Region, 2022 & 2032 (%)
8.6 Convenience Stores
8.6.1 Market Forecast by Region, 2022-2032 (US$ bn)
8.6.2 Market Share by Region, 2022 & 2032 (%)
8.7 Online Drugstores
8.7.1 Market Forecast by Region, 2022-2032 (US$ bn)
8.7.2 Market Share by Region, 2022 & 2032 (%)
8.8 Health Food Stores
8.8.1 Market Forecast by Region, 2022-2032 (US$ bn)
8.8.2 Market Share by Region, 2022 & 2032 (%)
8.9 Others
8.9.1 Market Forecast by Region, 2022-2032 (US$ bn)
8.9.2 Market Share by Region, 2022 & 2032 (%)

9 OTC Drugs & Dietary Supplements Market Analysis by Region
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast

10 North America OTC Drugs & Dietary Supplements Market Analysis
10.1 Key Findings
10.2 North America OTC Drugs & Dietary Supplements Market Attractiveness Index
10.3 Market Size by Country, 2022, 2027 & 2032 (US$ bn)
10.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ bn)
10.5 Market Size Estimation and Forecast by Category, 2022-2032 (US$ bn)
10.6 Market Size Estimation and Forecast by Dosage Form, 2022-2032 (US$ bn)
10.7 Market Size Estimation and Forecast by Product Type, 2022-2032 (US$ bn)
10.8 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ bn)
10.9 U.S.
10.10 Canada

11 Europe OTC Drugs & Dietary Supplements Market Analysis
11.1 Key Findings
11.2 Europe OTC Drugs & Dietary Supplements Market Attractiveness Index
11.3 Market Size by Country, 2022, 2027 & 2032 (US$ bn)
11.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ bn)
11.5 Market Size Estimation and Forecast by Category, 2022-2032 (US$ bn)
11.6 Market Size Estimation and Forecast by Dosage Form, 2022-2032 (US$ bn)
11.7 Market Size Estimation and Forecast by Product Type, 2022-2032 (US$ bn)
11.8 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ bn)
11.9 Germany
11.10 UK
11.11 France
11.12 Italy
11.13 Spain
11.14 Russia
11.15 Belgium
11.16 Switzerland
11.17 Netherlands
11.18 Rest of Europe

12 Asia Pacific OTC Drugs & Dietary Supplements Market Analysis
12.1 Key Findings
12.2 Asia Pacific OTC Drugs & Dietary Supplements Market Attractiveness Index
12.3 Market Size by Country, 2022, 2027 & 2032 (US$ bn)
12.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ bn)
12.5 Market Size Estimation and Forecast by Category, 2022-2032 (US$ bn)
12.6 Market Size Estimation and Forecast by Dosage Form, 2022-2032 (US$ bn)
12.7 Market Size Estimation and Forecast by Product Type, 2022-2032 (US$ bn)
12.8 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ bn)
12.9 Japan
12.10 China
12.11 India
12.12 South Korea
12.13 Australia
12.14 Singapore
12.15 Thailand
12.16 Malaysia
12.17 Indonesia
12.18 Philippines
12.19 Rest of Asia Pacific

13 Latin America OTC Drugs & Dietary Supplements Market Analysis
13.1 Key Findings
13.2 Latin America OTC Drugs & Dietary Supplements Market Attractiveness Index
13.3 Market Size by Country, 2022, 2027 & 2032 (US$ bn)
13.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ bn)
13.5 Market Size Estimation and Forecast by Category, 2022-2032 (US$ bn)
13.6 Market Size Estimation and Forecast by Dosage Form, 2022-2032 (US$ bn)
13.7 Market Size Estimation and Forecast by Product Type, 2022-2032 (US$ bn)
13.8 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ bn)
13.9 Brazil
13.10 Mexico
13.11 Argentina
13.12 Colombia
13.13 Rest of Latin America

14 MEA OTC Drugs & Dietary Supplements Market Analysis
14.1 Key Findings
14.2 MEA OTC Drugs & Dietary Supplements Market Attractiveness Index
14.3 Market Size by Country, 2022, 2027 & 2032 (US$ bn)
14.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ bn)
14.5 Market Size Estimation and Forecast by Category, 2022-2032 (US$ bn)
14.6 Market Size Estimation and Forecast by Dosage Form, 2022-2032 (US$ bn)
14.7 Market Size Estimation and Forecast by Product Type, 2022-2032 (US$ bn)
14.8 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ bn)
14.9 South Africa
14.10 Turkey
14.11 Saudi Arabia
14.12 UAE
14.13 Qatar
14.14 Rest of MEA

15 Company Profiles
15.1 Johnson & Johnson Services, Inc.
15.1.1 Company Snapshot
15.1.2 Company Overview
15.1.3 Financial Analysis
15.1.3.1 Net Revenue, 2017-2021
15.1.3.2 Gross Profit, 2017-2021
15.1.3.3 R&D, 2017-2021
15.1.4 Product Benchmarking
15.1.5 Strategic Outlook
15.2 Haleon plc
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Product Benchmarking
15.2.4 Strategic Outlook
15.3 Sanofi
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2017-2021
15.3.3.2 Gross Profit, 2017-2021
15.3.3.3 R&D, 2017-2021
15.3.4 Product Benchmarking
15.3.5 Strategic Outlook
15.4 Reckitt Benckiser Group PLC
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2017-2021
15.4.3.2 Gross Profit, 2017-2021
15.4.4 Product Benchmarking
15.4.5 Strategic Outlook
15.5 Bayer AG
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2017-2021
15.5.3.2 Gross Profit, 2017-2021
15.5.3.3 R&D, 2017-2021
15.5.4 Product Benchmarking
15.5.5 Strategic Outlook
15.6 Perrigo Company plc
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2017-2021
15.6.3.2 Gross Profit, 2017-2021
15.6.3.3 R&D, 2017-2021
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.7 Viatris Inc.
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2017-2021
15.7.3.2 Gross Profit, 2017-2021
15.7.3.3 R&D, 2017-2021
15.7.4 Product Benchmarking
15.7.5 Strategic Outlook
15.8 Takeda Pharmaceutical Company Limited
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2017-2021
15.8.3.2 Gross Profit, 2017-2021
15.8.3.3 R&D, 2017-2021
15.8.4 Product Benchmarking
15.8.5 Strategic Outlook
15.9 Taisho Pharmaceutical Holdings Co., Ltd.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Financial Analysis
15.9.3.1 Net Revenue, 2017-2021
15.9.3.2 R&D, 2017-2021
15.9.4 Product Benchmarking
15.9.5 Strategic Outlook
15.10 Nippon Chemiphar Co., Ltd.
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.3.1 Net Revenue, 2017-2021
15.10.3.2 R&D, 2017-2021
15.10.4 Product Benchmarking
15.10.5 Strategic Outlook
15.11 H. Lundbeck A/S
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2017-2021
15.11.3.2 R&D, 2017-2021
15.11.4 Product Benchmarking
15.11.5 Strategic Outlook
15.12 Teva Pharmaceutical Industries Ltd.
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Financial Analysis
15.12.3.1 Net Revenue, 2017-2021
15.12.3.2 Gross Profit, 2017-2021
15.12.3.3 R&D, 2017-2021
15.12.4 Product Benchmarking
15.12.5 Strategic Outlook
15.13 Novartis AG
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Financial Analysis
15.13.3.1 Net Revenue, 2017-2021
15.13.3.2 Gross Profit, 2017-2021
15.13.3.3 R&D, 2017-2021
15.13.4 Product Benchmarking
15.13.5 Strategic Outlook
15.14 Pfizer Inc.
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Financial Analysis
15.14.3.1 Net Revenue, 2017-2021
15.14.3.2 Gross Profit, 2017-2021
15.14.3.3 R&D, 2017-2021
15.14.4 Product Benchmarking
15.14.5 Strategic Outlook
15.15 Abbott
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Financial Analysis
15.15.3.1 Net Revenue, 2017-2021
15.15.3.2 Gross Profit, 2017-2021
15.15.3.3 R&D, 2017-2021
15.15.4 Product Benchmarking
15.15.5 Strategic Outlook
15.16 Fresenius Medical Care AG & Co. KGaA
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Financial Analysis
15.16.3.1 Net Revenue, 2017-2021
15.16.3.2 Gross Profit, 2017-2021
15.16.3.3 R&D, 2017-2021
15.16.4 Product Benchmarking
15.16.5 Strategic Outlook
15.17 Sun Pharmaceutical Industries Ltd.
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Financial Analysis
15.17.3.1 Net Revenue, 2018-2021
15.17.4 Product Benchmarking
15.17.5 Strategic Outlook
15.18 F. Hoffmann-La Roche Ltd
15.18.1 Company Snapshot
15.18.2 Company Overview
15.18.3 Financial Analysis
15.18.3.1 Net Revenue, 2017-2021
15.18.3.2 Gross Profit, 2017-2021
15.18.3.3 R&D, 2017-2021
15.18.4 Product Benchmarking
15.18.5 Strategic Outlook
15.19 Lupin
15.19.1 Company Snapshot
15.19.2 Company Overview
15.19.3 Product Benchmarking
15.19.4 Strategic Outlook
15.20 Alcon
15.20.1 Company Snapshot
15.20.2 Company Overview
15.20.3 Financial Analysis
15.20.3.1 Net Revenue, 2017-2021
15.20.3.2 Gross Profit, 2017-2021
15.20.3.3 R&D, 2017-2021
15.20.4 Product Benchmarking
15.20.5 Strategic Outlook
15.21 Herbalife International of America, Inc.
15.21.1 Company Snapshot
15.21.2 Company Overview
15.21.3 Product Benchmarking
15.22 Glanbia PLC
15.22.1 Company Snapshot
15.22.2 Company Overview
15.22.3 Financial Analysis
15.22.3.1 Net Revenue, 2017-2021
15.22.3.2 Gross Profit, 2017-2021
15.22.4 Product Benchmarking
15.23 Nature’s Sunshine Products, Inc.
15.23.1 Company Snapshot
15.23.2 Company Overview
15.23.3 Product Benchmarking
15.24 Alkem Labs
15.24.1 Company Snapshot
15.24.2 Company Overview
15.24.3 Financial Analysis
15.24.3.1 Net Revenue, 2017-2021
15.24.4 Product Benchmarking
15.24.5 Strategic Outlook
15.25 Cipla Inc.
15.25.1 Company Snapshot
15.25.2 Company Overview
15.25.3 Financial Analysis
15.25.3.1 Net Revenue, 2017-2021
15.25.4 Product Benchmarking
15.25.5 Strategic Outlook
15.26 Dr. Reddy’s Laboratories Ltd.
15.26.1 Company Snapshot
15.26.2 Company Overview
15.26.3 Financial Analysis
15.26.3.1 Net Revenue, 2017-2021
15.26.3.2 Gross Profit, 2017-2021
15.26.3.3 R&D, 2017-2021
15.26.4 Product Benchmarking
15.26.5 Strategic Outlook

16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players

List of Tables
Table 1 OTC Drugs & Dietary Supplements Market Snapshot, 2022 & 2032 (US$ billion, CAGR %)
Table 2 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): “V” Shaped Recovery
Table 3 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): “U” Shaped Recovery
Table 4 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): “W” Shaped Recovery
Table 5 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): “L” Shaped Recovery
Table 6 OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 7 Cough, Cold and Flu Drugs Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 8 Analgesics Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 9 Dermatological Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 10 Vitamins and Minerals Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 11 Weight Loss/Diet Products Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 12 Gastrointestinal Drugs Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 13 Allergy Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 14 Others Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 15 OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 16 Tablets Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 17 Hard Capsules Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 18 Powders Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 19 Ointments Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 20 Soft Capsules Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 21 Liquids Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 22 Others Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 23 OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 24 Branded Drugs Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 25 Generic Drugs Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 26 OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 27 Pharmacies/Drugstores Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 28 Supermarkets/Hypermarkets Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 29 Convenience Stores Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 30 Online Drug Stores Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 31 Health Food Stores Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 32 Others Segment Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 33 OTC Drugs & Dietary Supplements Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 34 North America OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 35 North America OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 36 North America OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 37 North America OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 38 North America OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 39 U.S. OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 40 Canada OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 41 Europe OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 42 Europe OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 43 Europe OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 44 Europe OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 45 Europe OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 46 Germany OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 47 UK OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 48 France OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 49 Italy OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 50 Spain OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 51 Russia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 52 Belgium OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 53 Switzerland OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 54 Netherlands OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 55 Rest of Europe OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 56 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 57 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 58 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 59 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 60 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 61 Japan OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 62 China OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 63 India OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 64 South Korea OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 65 Australia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 66 Singapore OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 67 Thailand OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 68 Malaysia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 69 Indonesia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 70 Philippines OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 71 Rest of Asia Pacific OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 72 Latin America OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 73 Latin America OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 74 Latin America OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 75 Latin America OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 76 Latin America OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 77 Brazil OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 78 Mexico OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 79 Argentina OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 80 Colombia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 81 Rest of Latin America OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 82 MEA OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 83 MEA OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 84 MEA OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 85 MEA OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 86 MEA OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 87 South Africa OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 88 Turkey OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 89 Saudi Arabia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 90 UAE OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 91 Qatar OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 92 Rest of MEA Arabia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 93 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 Johnson & Johnson Services, Inc.: Product Benchmarking
Table 95 Johnson & Johnson Services, Inc.: Strategic Outlook
Table 96 Haleon plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Haleon plc: Product Benchmarking
Table 98 Haleon plc: Strategic Outlook
Table 99 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Sanofi: Product Benchmarking
Table 101 Sanofi: Strategic Outlook
Table 102 Reckitt Benckiser Group PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Reckitt Benckiser Group PLC: Product Benchmarking
Table 104 Reckitt Benckiser Group PLC: Strategic Outlook
Table 105 Bayer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Bayer AG: Product Benchmarking
Table 107 Bayer AG: Strategic Outlook
Table 108 Perrigo Company plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 Perrigo Company plc: Product Benchmarking
Table 110 Perrigo Company plc: Strategic Outlook
Table 111 Viatris Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Viatris Inc.: Product Benchmarking
Table 113 Viatris Inc.: Strategic Outlook
Table 114 Takeda Pharmaceutical Company Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Takeda Pharmaceutical Company Limited: Product Benchmarking
Table 116 Takeda Pharmaceutical Company Limited: Strategic Outlook
Table 117 Taisho Pharmaceutical Holdings Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Taisho Pharmaceutical Holdings Co., Ltd.: Product Benchmarking
Table 119 Taisho Pharmaceutical Holdings Co., Ltd.: Strategic Outlook
Table 120 Nippon Chemiphar Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 Nippon Chemiphar Co., Ltd.: Product Benchmarking
Table 122 Nippon Chemiphar Co., Ltd.: Strategic Outlook
Table 123 H. Lundbeck A/S: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 H. Lundbeck A/S: Product Benchmarking
Table 125 H. Lundbeck A/S: Strategic Outlook
Table 126 Teva Pharmaceutical Industries Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Teva Pharmaceutical Industries Ltd.: Product Benchmarking
Table 128 Teva Pharmaceutical Industries Ltd.: Strategic Outlook
Table 129 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Novartis AG: Product Benchmarking
Table 131 Novartis AG: Strategic Outlook
Table 132 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 Pfizer Inc.: Product Benchmarking
Table 134 Pfizer Inc.: Strategic Outlook
Table 135 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 Abbott: Product Benchmarking
Table 137 Abbott: Strategic Outlook
Table 138 Fresenius Medical Care AG & Co. KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 139 Fresenius Medical Care AG & Co. KGaA: Product Benchmarking
Table 140 Fresenius Medical Care AG & Co. KGaA: Strategic Outlook
Table 141 Sun Pharmaceutical Industries Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 142 Sun Pharmaceutical Industries Ltd.: Product Benchmarking
Table 143 Sun Pharmaceutical Industries Ltd.: Strategic Outlook
Table 144 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 145 F. Hoffmann-La Roche Ltd: Product Benchmarking
Table 146 F. Hoffmann-La Roche Ltd: Strategic Outlook
Table 147 Lupin: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 148 Lupin: Product Benchmarking
Table 149 Lupin: Strategic Outlook
Table 150 Alcon: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 151 Alcon: Product Benchmarking
Table 152 Alcon: Strategic Outlook
Table 153 Herbalife International of America, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 154 Herbalife International of America, Inc.: Product Benchmarking
Table 155 Glanbia PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 156 Glanbia PLC: Product Benchmarking
Table 157 Nature’s Sunshine Products, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 158 Nature’s Sunshine Products, Inc.: Product Benchmarking
Table 159 Alkem Labs: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 160 Alkem Labs: Product Benchmarking
Table 161 Alkem Labs: Strategic Outlook
Table 162 Cipla Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 163 Cipla Inc.: Product Benchmarking
Table 164 Cipla Inc.: Strategic Outlook
Table 165 Dr. Reddy’s Laboratories Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 166 Dr. Reddy’s Laboratories Ltd.: Product Benchmarking
Table 167 Dr. Reddy’s Laboratories Ltd.: Strategic Outlook
?

List of Figures
Figure 1 OTC Drugs & Dietary Supplements Market Segmentation
Figure 2 OTC Drugs & Dietary Supplements Market by Category: Market Attractiveness Index
Figure 3 OTC Drugs & Dietary Supplements Market by Dosage Form: Market Attractiveness Index
Figure 4 OTC Drugs & Dietary Supplements Market by Product Type: Market Attractiveness Index
Figure 5 OTC Drugs & Dietary Supplements Market by Distribution Channel: Market Attractiveness Index
Figure 6 OTC Drugs & Dietary Supplements Market Attractiveness Index by Region
Figure 7 OTC Drugs & Dietary Supplements Market: Market Dynamics
Figure 8 COVID Impact Analysis: OTC Drugs & Dietary Supplements Market Recovery Scenarios
Figure 9 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn, AGR %): “V” Shaped Recovery
Figure 10 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn, AGR %): “U” Shaped Recovery
Figure 11 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn, AGR %): “W” Shaped Recovery
Figure 12 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn, AGR %): “L” Shaped Recovery
Figure 13 OTC Drugs & Dietary Supplements Market: Porter’s Five Forces Analysis
Figure 14 OTC Pharmaceutical Supply Chain
Figure 15 OTC Drugs & Dietary Supplements Market Attractiveness Index by Category
Figure 16 OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 17 OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022, 2027, 2032 (%)
Figure 18 Cough, Cold and Flu Drugs Market Forecast by Region, 2022-2032 (US$ billion)
Figure 19 Cough, Cold and Flu Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 20 Analgesics Market Forecast by Region, 2022-2032 (US$ billion)
Figure 21 Analgesics Market Share Forecast by Region, 2022 & 2032 (%)
Figure 22 Dermatological Market Forecast by Region, 2022-2032 (US$ billion)
Figure 23 Dermatological Market Share Forecast by Region, 2022 & 2032 (%)
Figure 24 Vitamins and Minerals Market Forecast by Region, 2022-2032 (US$ billion)
Figure 25 Vitamins and Minerals Market Share Forecast by Region, 2022 & 2032 (%)
Figure 26 Weight Loss/Diet Products Market Forecast by Region, 2022-2032 (US$ billion)
Figure 27 Weight Loss/Diet Products Market Share Forecast by Region, 2022 & 2032 (%)
Figure 28 Gastrointestinal Drugs Market Forecast by Region, 2022-2032 (US$ billion)
Figure 29 Gastrointestinal Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 30 Allergy Market Forecast by Region, 2022-2032 (US$ billion)
Figure 31 Allergy Market Share Forecast by Region, 2022 & 2032 (%)
Figure 32 Others Market Forecast by Region, 2022-2032 (US$ billion)
Figure 33 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 34 OTC Drugs & Dietary Supplements Market Attractiveness Index by Category
Figure 35 OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 36 OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022, 2027, 2032 (%)
Figure 37 Tablets Market Forecast by Region, 2022-2032 (US$ billion)
Figure 38 Tablets Market Share Forecast by Region, 2022 & 2032 (%)
Figure 39 Hard Capsules Market Forecast by Region, 2022-2032 (US$ billion)
Figure 40 Hard Capsules Market Share Forecast by Region, 2022 & 2032 (%)
Figure 41 Powders Market Forecast by Region, 2022-2032 (US$ billion)
Figure 42 Powders Market Share Forecast by Region, 2022 & 2032 (%)
Figure 43 Ointments Market Forecast by Region, 2022-2032 (US$ billion)
Figure 44 Ointments Market Share Forecast by Region, 2022 & 2032 (%)
Figure 45 Soft Capsules Market Forecast by Region, 2022-2032 (US$ billion)
Figure 46 Soft Capsules Market Share Forecast by Region, 2022 & 2032 (%)
Figure 47 Liquids Market Forecast by Region, 2022-2032 (US$ billion)
Figure 48 Liquids Market Share Forecast by Region, 2022 & 2032 (%)
Figure 49 Others Market Forecast by Region, 2022-2032 (US$ billion)
Figure 50 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 51 OTC Drugs & Dietary Supplements Market Attractiveness Index by Product Type
Figure 52 OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 53 OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022, 2027, 2032 (%)
Figure 54 Branded Drugs Market Forecast by Region, 2022-2032 (US$ billion)
Figure 55 Branded Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 56 Generic Drugs Market Forecast by Region, 2022-2032 (US$ billion)
Figure 57 Generic Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 58 OTC Drugs & Dietary Supplements Market Attractiveness Index by Distribution Channel
Figure 59 OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 60 OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022, 2027, 2032 (%)
Figure 61 Pharmacies/Drugstores Market Forecast by Region, 2022-2032 (US$ billion)
Figure 62 Pharmacies/Drugstores Market Share Forecast by Region, 2022 & 2032 (%)
Figure 63 Supermarkets/Hypermarkets Market Forecast by Region, 2022-2032 (US$ billion)
Figure 64 Supermarkets/Hypermarkets Market Share Forecast by Region, 2022 & 2032 (%)
Figure 65 Convenience Stores Market Forecast by Region, 2022-2032 (US$ billion)
Figure 66 Convenience Stores Market Share Forecast by Region, 2022 & 2032 (%)
Figure 67 Online Drugstores Market Forecast by Region, 2022-2032 (US$ billion)
Figure 68 Online Drugstores Market Share Forecast by Region, 2022 & 2032 (%)
Figure 69 Health Food Stores Market Forecast by Region, 2022-2032 (US$ billion)
Figure 70 Health Food Stores Market Share Forecast by Region, 2022 & 2032 (%)
Figure 71 Others Market Forecast by Region, 2022-2032 (US$ billion)
Figure 72 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 73 OTC Drugs & Dietary Supplements Market Forecast by Region 2022 & 2032 (Revenue, CAGR%)
Figure 74 OTC Drugs & Dietary Supplements Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 75 OTC Drugs & Dietary Supplements Market by Region, 2022-2032 (US$ bn)
Figure 76 North America OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 77 North America OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 78 North America OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 79 North America OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 80 North America OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 81 North America OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 82 North America OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 83 North America OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 84 North America OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 85 North America OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 86 North America OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 87 North America OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 88 U.S. OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 89 Canada OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 90 Europe OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 91 Europe OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 92 Europe OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 93 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 94 Europe OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 95 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 96 Europe OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 97 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 98 Europe OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 99 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 100 Europe OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 101 Europe OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 102 Germany OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 103 UK OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 104 France OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 105 Italy OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 106 Spain OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 107 Russia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 108 Belgium OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 109 Switzerland OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 110 Netherlands OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 111 Rest of Europe OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 112 Asia Pacific OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 113 Asia Pacific OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 114 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 115 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 116 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 117 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 118 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 119 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 120 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 121 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 122 Asia Pacific OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 123 Asia Pacific OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 124 Japan OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 125 China OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 126 India OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 127 South Korea OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 128 Australia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 129 Singapore OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 130 Thailand OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 131 Malaysia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 132 Indonesia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 133 Philippines OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 134 Rest of Asia Pacific OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 135 Latin America OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 136 Latin America OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 137 Latin America OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 138 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 139 Latin America OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 140 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 141 Latin America OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 142 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 143 Latin America OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 144 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 145 Latin America OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 146 Latin America OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 147 Brazil OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 148 Mexico OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 149 Argentina OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 150 Colombia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 151 Rest of Latin America OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 152 MEA OTC Drugs & Dietary Supplements Market Attractiveness Index
Figure 153 MEA OTC Drugs & Dietary Supplements Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 154 MEA OTC Drugs & Dietary Supplements Market Forecast by Country, 2022-2032 (US$ billion)
Figure 155 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Country, 2022 & 2032 (%)
Figure 156 MEA OTC Drugs & Dietary Supplements Market Forecast by Category, 2022-2032 (US$ billion)
Figure 157 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Category, 2022 & 2032 (%)
Figure 158 MEA OTC Drugs & Dietary Supplements Market Forecast by Dosage Form, 2022-2032 (US$ billion)
Figure 159 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Dosage Form, 2022 & 2032 (%)
Figure 160 MEA OTC Drugs & Dietary Supplements Market Forecast by Product Type, 2022-2032 (US$ billion)
Figure 161 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Product Type, 2022 & 2032 (%)
Figure 162 MEA OTC Drugs & Dietary Supplements Market Forecast by Distribution Channel, 2022-2032 (US$ billion)
Figure 163 MEA OTC Drugs & Dietary Supplements Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 164 South Africa OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 165 Turkey OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 166 Saudi Arabia OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 167 UAE OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 168 Qatar OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 169 Rest of MEA OTC Drugs & Dietary Supplements Market Forecast, 2022-2032 (US$ billion)
Figure 170 Johnson & Johnson Services, Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 171 Johnson & Johnson Services, Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 172 Johnson & Johnson Services, Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 173 Sanofi: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 174 Sanofi: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 175 Sanofi: R&D, 2017-2021 (US$ million, AGR%)
Figure 176 Reckitt Benckiser Group PLC: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 177 Reckitt Benckiser Group PLC: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 178 Bayer AG: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 179 Bayer AG: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 180 Bayer AG: R&D, 2017-2021 (US$ million, AGR%)
Figure 181 Perrigo Company plc: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 182 Perrigo Company plc: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 183 Perrigo Company plc: R&D, 2017-2021 (US$ million, AGR%)
Figure 184 Viatris Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 185 Viatris Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 186 Viatris Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 187 Takeda Pharmaceutical Company Limited: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 188 Takeda Pharmaceutical Company Limited: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 189 Takeda Pharmaceutical Company Limited: R&D, 2017-2021 (US$ million, AGR%)
Figure 190 Taisho Pharmaceutical Holdings Co., Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 191 Taisho Pharmaceutical Holdings Co., Ltd.: R&D, 2017-2021 (US$ million, AGR%)
Figure 192 Nippon Chemiphar Co., Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 193 Nippon Chemiphar Co., Ltd.: R&D, 2017-2021 (US$ million, AGR%)
Figure 194 H. Lundbeck A/S: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 195 H. Lundbeck A/S: R&D, 2017-2021 (US$ million, AGR%)
Figure 196 Teva Pharmaceutical Industries Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 197 Teva Pharmaceutical Industries Ltd.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 198 Teva Pharmaceutical Industries Ltd.: R&D, 2017-2021 (US$ million, AGR%)
Figure 199 Novartis AG: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 200 Novartis AG: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 201 Novartis AG: R&D, 2017-2021 (US$ million, AGR%)
Figure 202 Pfizer Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 203 Pfizer Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 204 Pfizer Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 205 Abbott: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 206 Abbott: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 207 Abbott: R&D, 2017-2021 (US$ million, AGR%)
Figure 208 Fresenius Medical Care AG & Co. KGaA: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 209 Fresenius Medical Care AG & Co. KGaA: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 210 Fresenius Medical Care AG & Co. KGaA: R&D, 2017-2021 (US$ million, AGR%)
Figure 211 Sun Pharmaceutical Industries Ltd.: Net Revenue, 2018-2021 (US$ million, AGR%)
Figure 212 F. Hoffmann-La Roche Ltd: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 213 F. Hoffmann-La Roche Ltd: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 214 F. Hoffmann-La Roche Ltd: R&D, 2017-2021 (US$ million, AGR%)
Figure 215 Alcon: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 216 Alcon: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 217 Alcon: R&D, 2017-2021 (US$ million, AGR%)
Figure 218 Glanbia PLC: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 219 Glanbia PLC: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 220 Alkem Labs: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 221 Cipla Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 222 Dr. Reddy’s Laboratories Ltd.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 223 Dr. Reddy’s Laboratories Ltd.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 224 Dr. Reddy’s Laboratories Ltd.: R&D, 2017-2021 (US$ million, AGR%)